People

Nicholas Saccomano

Nicholas A. Saccomano, PhD, is a Modulo Bio board director announced inJuly2025 and previously disclosed inNovember2024. The issuer describes four decades of drug discovery experience, including leadership at OnKure, Pfizer, Array BioPharma and SomaLogic. He earned a Columbia organic chemistry PhD and a SUNY Buffalo bachelor’s degree. Those career titles are source-dated to the announcement rather than asserted as current2026 employment. Retained earlier biography: Nicholas A. Saccomano advises Engine Biosciences on drug discovery. His earlier positions included Pfizer’s Boulder research-site leadership, chief scientific officer at Array Biopharma and chief technology officer at SomaLogic. He holds a Columbia organic-chemistry doctorate.